Modulite® inhaler technology: Practical device features for asthma and COPD management

Description

In this Quick Case, Consultant Pharmacist A/Prof Debbie Rigby discusses the role of Modulite® technology in asthma and COPD inhalers, highlighting device characteristics, inhaler selection considerations, and the potential relationship of extrafine (<2 µm MMAD) particle delivery on lung deposition (4 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel – A/Prof Samantha Hocking & Dr Terri-Lynne South, facilitated by A/Prof Ralph Audehm

Expert panel – A/Prof Samantha Hocking & Dr Terri-Lynne South, facilitated by A/Prof Ralph Audehm

GLP 1s & Sarcopenia: Fact vs Hype

Dr Deb Mills

Dr Deb Mills

The New Dengue Vaccine – What You Need to Know

Dr Robert Hungerford

Dr Robert Hungerford

Hypertriglyceridaemia – Causes, Assessment & Management of CV Risk

A/Prof Michelle Rodrigues

A/Prof Michelle Rodrigues

Management of Photoageing

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Debbie Rigby

expert

A/Prof Debbie Rigby

Consultant Pharmacist; Clinical Executive Lead, National Asthma Council Australia

Date published: 29 September 2026